Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset Juvenile dermatomyositis

Arthritis and Rheumatism

Volumn 60, Issue 4, 2009, Pages 1160-1172

  De Padilla, Consuelo M López ^a   Vallejo, Abbe N ^b,c   Lacomis, David ^c   Mcnallan, Kelly ^a   Reed, Ann M ^a,d  

^a Mayo Clinic   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CORTICOSTEROID; CXCL13 CHEMOKINE; CYCLOSPORIN; IMMUNOGLOBULIN; LYMPHOTOXIN; LYMPHOTOXIN BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; METHOTREXATE; RITUXIMAB; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CELL COMPOSITION; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DERMATOMYOSITIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH FOLLICLE; LYMPHOCYTE; LYMPHOID CELL; MALE; MICROCHIMERISM; MUSCLE BIOPSY; ORGANOGENESIS; PLASMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ANTIGENS, CD20; ANTIGENS, CD45; B-LYMPHOCYTES; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL13; CHILD; CHILD, PRESCHOOL; CHIMERISM; DENDRITIC CELLS, FOLLICULAR; DERMATOMYOSITIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MALE; MUSCLE, SKELETAL; SEVERITY OF ILLNESS INDEX; SKIN; VENULES; YOUNG ADULT;

EID: 65249167531     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24411     Document Type: Article

References (49)

1. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 1966;45:261-89.
2. Pachman LM. Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression. Rheum Dis Clin North Am 2002;28:579-602.
3. Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum 2007;57:1183-91.
4. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002:28:833-57.
5. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995:37 Suppl l:S74-86.
6. De Bleecker JL, Engel AG, Butcher EC. Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies. Neuromuscul Disord 1996:6:255-60.
7. Lopez de Padilla CM, Vallejo AN, McNallan KT, Vehe R, Smith SA, Dietz AB, et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 2007;56:1658-68.
8. Cavanagh LL, Boyce A, Smith L, Padmanabha J, Filgueira L, Pietschmann P, et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005;7:R230-40.
9. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P. Involvement of plasmacytoid dendritic cells in human diseases. Hum Immunol 2002;63:1201-5.
10. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919-23.
11. Lopez de Padilla CM, Reed AM. Involvement of dendritic cells in autoimmune diseases in children. Pediatr Rheumatol Online J 2007;5:16.
12. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002;169:424-33.
13. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001;69:331-9.
14. Weyand C, Kurtin P, Goronzy J. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol 2001;159:789-93.
15. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001; 167:1072-80.
16. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-41.
17. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 2001;44:2633-41.
18. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001;159:861-73.
19. Weninger W, Carlsen HS, Goodarzi M, Moazed F, Crowley MA, Baekkevold ES, et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003;170:4638-48.
20. Aust G, Sittig D, Becherer L, Anderegg U, Schutz A, Lamesch P, et al. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol 2004;150:225-34.
21. Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH. Ectopic LTa/3 directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med 2003;197:1153-63.
22. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006;7: 344-53.
23. Aloisi F, Pujol-Borrel R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6:205-17.
24. Reed AM, McNallan K, Wettstein P, Vehe R, Ober C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004;172:5041-6.
25. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
26. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al, for the International Myositis Assessment and Clinical Studies Group. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005;52:2607-15.
27. McNallan KT, Aponte C, el-Azhary R, Mason T, Nelson AM, Paat JJ, et al. Immunophenotyping of chimeric cells in localized scleroderma. Rheumatology (Oxford) 2007;46:398-402.
28. T method. Methods 2001;25:402-8.
29. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
30. Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Oilier WE, et al, on behalf of the Juvenile Dermatomyositis Research Group (JDRG). HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology (Oxford) 2007;46:1786-91.
31. Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M. The low-affinity receptor for IgE. Immunol Rev 1992;125:77-97.
32. Van Nierop K, de Groot C. Human follicular dendritic cells: function, origin and development. Semin Immunol 2002;14:251-7.
33. Liu YJ, de Bouteiller O, Parham CL, Grouard G, Djossou O, de Saint-Vis B, et al. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Med 1997;185:165-70.
34. Raymond I, Al Saati T, Tkaczuk J, Chittal S, Delsol G. CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells. Am J Pathol 1997; 151:1577-85.
35. Girard JP, Springer TA. High endothelial venules (HEVs) : specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-57.
36. Duijvestijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, et al. High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988;130:147-55.
37. Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, Wang J, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity 2006;25:499-509.
38. O'Hanlon TP, Messersmith WA, Dalakas MC, Plotz PH, Miller FW. γδ T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. Clin Exp Immunol 1995;100:519-28.
39. Reed AM, Picornell YJ, Harwood A, Kredich DW. Chimerism in children with juvenile dermatomyositis. Lancet 2000;356:2156-7.
40. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Childhood Myositis Heterogeneity Collaborative Group. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 2000;356:2155-6.
41. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
42. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigendriven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjogren's syndrome. J Clin Invest 1998;102:938-46.
43. Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: primary Sjögren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol 2006;2:262-9.
44. Sarkar S, Fox DA. Dendritic cells in rheumatoid arthritis. Front Biosci 2005;10:656-65.
45. Kremer Hovinga IC, Koopmans M, Baelde HJ, de Heer E, Bruijn JA, Bajema IM. Tissue chimerism in systemic lupus erythematosus is related to injury. Ann Rheum Dis 2007;66:1568-73.
46. Muller G, Lipp M. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 2003;15:217-24.
47. Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, et al, on behalf of the UK Juvenile Dermatomyositis Research Group. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007;57:1192-201.
48. Noss EH, Hausner-Sypek DL, Weinblatt ME. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 2006;33:1021-6.
49. Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Arthritis Rheum 2007;56:3107-11.